4//SEC Filing
Goeltz II Robert C. 4
Accession 0001653881-25-000005
CIK 0001724521other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 8:54 AM ET
Size
4.7 KB
Accession
0001653881-25-000005
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-10-28$20.00/sh−5,000$100,000→ 92,138 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001653881
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 8:54 AM ET
- Size
- 4.7 KB